Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gregory Renza Initiated (catx) at Buy and Held Target at $30 on, May 14th, 2024
Gregory Renza of RBC Capital, Initiated "Perspective Therapeutics, Inc." (CATX) at Buy and Held Target at $30 on, May 14th, 2024.
Gregory has made no other calls on CATX in the last 4 months.
There are 3 other peers that have a rating on CATX. Out of the 3 peers that are also analyzing CATX, 0 agree with Gregory's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Gregory
- Louis Chen of "Cantor Fitzgerald" Initiated at Buy on, Thursday, May 9th, 2024
- Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $17 on, Tuesday, April 9th, 2024
- Jeff Jones of "Oppenheimer" Reiterated at Buy with Increased Target to $15 on, Monday, April 1st, 2024
Contributing Sources